Back
Results - Announcements
Sales rise 13.38% to Rs 4.83 crore
Parmax Pharma reports standalone net loss of Rs 1.49 crore in the March 2025 quarter
31-May-2025, 03:44
Net Loss of Parmax Pharma reported to Rs 1.49 crore in the quarter ended March 2025 as against net loss of Rs 1.45 crore during the previous quarter ended March 2024. Sales rose 13.38% to Rs 4.83 crore in the quarter ended March 2025 as against Rs 4.26 crore during the previous quarter ended March 2024.
Net Loss of Parmax Pharma reported to Rs 1.49 crore in the quarter ended March 2025 as against net loss of Rs 1.45 crore during the previous quarter ended March 2024. Sales rose 13.38% to Rs 4.83 crore in the quarter ended March 2025 as against Rs 4.26 crore during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 2.09 crore in the year ended March 2025 as against net loss of Rs 5.75 crore during the previous year ended March 2024. Sales rose 155.20% to Rs 28.20 crore in the year ended March 2025 as against Rs 11.05 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. | |
| Sales | 4.83 | 4.26 | 13 | 28.20 | 11.05 | 155 |
| OPM % | -11.59 | -18.78 | - | 0.92 | -30.59 | - |
| PBDT | -0.90 | -0.95 | 5 | -0.29 | -3.95 | 93 |
| PBT | -0.72 | -1.36 | 47 | -1.32 | -5.66 | 77 |
| NP | -1.49 | -1.45 | -3 | -2.09 | -5.75 | 64 |
Powered by Capital Market - Live News